P3 Health Partners Inc.

Equities

PIII

US7444131053

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:05 2024-05-16 EDT			5-day change	1st Jan Change
0.6 ^USD	-2.34%		-18.02%	-57.45%

05-08	Earnings Flash (PIII) P3 HEALTH PARTNERS Reports Q1 Revenue $388.5M, vs. Street Est of $357.2M	MT
05-08	Transcript : P3 Health Partners Inc., Q1 2024 Earnings Call, May 08, 2024

P3 Health Partners Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022

March 31, 2023 at 07:31 am

P3 Health Partners Inc. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was USD 254 million compared to USD 181.4 million a year ago. Revenue was USD 258.2 million compared to USD 185.3 million a year ago.

Net loss was USD 94 million compared to USD 70.3 million a year ago. Basic loss per share from continuing operations was USD 2.26 compared to USD 1.69 a year ago. Diluted loss per share from continuing operations was USD 2.26 compared to USD 1.69 a year ago.

Latest news about P3 Health Partners Inc.

Earnings Flash (PIII) P3 HEALTH PARTNERS Reports Q1 Revenue $388.5M, vs. Street Est of $357.2M	05-08	MT
Transcript : P3 Health Partners Inc., Q1 2024 Earnings Call, May 08, 2024	05-08
P3 Health Partners Inc. Announces CEO Changes	05-08	CI
BTIG Research Downgrades P3 Health Partners to Neutral From Buy	04-01	MT
Transcript : P3 Health Partners Inc., Q4 2023 Earnings Call, Mar 28, 2024	03-28
P3 Health Partners Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Earnings Flash (PIII) P3 HEALTH PARTNERS Reports Q4 Revenue $346.9M, vs. Street Est of $302.7M	03-28	MT
P3 Health Partners Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-28	CI
P3 Health Partners Inc. Reaffirms Earnings Guidance for the full-year ending December 31, 2024	03-15	CI
Lake Street Adjusts Price Target on P3 Health Partners to $4.50 From $9, Maintains Buy Rating	03-14	MT
Transcript : P3 Health Partners Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 01:30 PM	01-10
Global markets live: J Sainsbury, Intel, Tesla, Boeing, Amazon...	01-10
P3 Health Partners Reaffirms 2023 Revenue Guidance, Issues 2024 Outlook	01-10	MT
In wait-and-see mode	01-10
P3 Health Partners Inc. Reaffirms Earnings Guidance for the Year Ended December 31, 2023 and Provides Earnings Guidance for the Year Ending December 31, 2024	01-09	CI
Transcript : P3 Health Partners Inc., Q3 2023 Earnings Call, Nov 08, 2023	11-08
Earnings Flash (PIII) P3 HEALTH PARTNERS Posts Q3 Revenue $288.4M, vs. Street Est of $293.3M	11-08	MT
P3 Health Partners Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-08	CI
P3 Health Partners Inc. Provides Earnings Guidance for the Year 2023	11-08	CI
BTIG Initiates P3 Health Partners With Buy Rating, Price Target is $5	23-09-01	MT
Transcript : P3 Health Partners Inc., Q2 2023 Earnings Call, Aug 07, 2023	23-08-07
Earnings Flash (PIII) P3 HEALTH PARTNERS Reports Q2 Revenue $329.1M, vs. Street Est of $303.3M	23-08-07	MT
P3 Health Partners Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
P3 Health Partners Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2023	23-08-07	CI
TD Cowen Initiates P3 Health Partners at Market Perform	23-06-30	MT

Chart P3 Health Partners Inc.

Duration

Period

More charts

Company Profile

P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patientâs care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from more than 250 disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 2,800 affiliated primary care providers across the country. Its local teams of health care professionals manage the care of thousands of patients in 23 counties across five states.

Sector

Biotechnology & Medical Research

Calendar

2024-06-06 - Annual General Meeting

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for P3 Health Partners Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.6 USD

Average target price

2.7 USD

Spread / Average Target

+350.00%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
P3 HEALTH PARTNERS INC.	-57.45%	73.49M
MODERNA, INC.	+33.37%	49.46B
IQVIA HOLDINGS INC.	+1.55%	42.58B
LONZA GROUP AG	+49.11%	42.49B
CELLTRION, INC.	-4.22%	29.09B
ICON PUBLIC LIMITED COMPANY	+11.57%	26.61B
ALNYLAM PHARMACEUTICALS, INC.	-21.00%	18.64B
BIO-TECHNE CORPORATION	+7.36%	13.16B
MEDPACE HOLDINGS, INC.	+28.30%	12.55B
UNITED THERAPEUTICS CORPORATION	+23.80%	12.1B

Other Biotechnology & Medical Research